NewsRx

Search our medical news database

Therapy (Thalassemia)

"Erythrocytapheresis to Lower Iron Loading in Thalassemia."

Published in Blood Weekly, April 26th, 1999

Grant Number: 1R01HL61185-01. Grant Expires: July 31, 2003. Principle Investigator: Alan R. Cohen. Performing Organization: Children's Hospital of Philadelphia, 34th St. and Civic Center Blvd, Philadelphia, Pennsylvania 19104. Description: "Transfusion therapy, the cornerstone of the treatment of thalassemia major, dramatically improves the quality and length of life of affected patients. However, iron overload is an inevitable, life-threatening complication of long-term administration of red cells. Iron chelation therapy with deferoxamine removes excessive iron, but the need for parenteral administration of the chelator, drug-related side...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Blood Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook